|
|
Volumn 3, Issue 4, 2014, Pages 429-447
|
|
Advances in recent patent and clinical trial drug development for Alzheimer's disease
|
|
Author keywords
Alzheimer s disease; amyloid (A ); patent; tau; therapeutic agents
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
CHOLINERGIC RECEPTOR STIMULATING AGENT;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NERVE GROWTH FACTOR;
SECRETASE;
TAU PROTEIN;
ALZHEIMER DISEASE;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL (TOPIC);
DRUG DEVELOPMENT;
DRUG EFFECTS;
HUMAN;
IMMUNOTHERAPY;
MITOCHONDRION;
PATENT;
PATHOPHYSIOLOGY;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
AMYLOID PRECURSOR PROTEIN SECRETASES;
CHOLINERGIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG DISCOVERY;
HUMANS;
IMMUNOTHERAPY;
MITOCHONDRIA;
NERVE GROWTH FACTORS;
PATENTS AS TOPIC;
RECEPTORS, N-METHYL-D-ASPARTATE;
TAU PROTEINS;
|
|
EID: 85017306803
PISSN: None
EISSN: 20468962
Source Type: Journal
DOI: 10.4155/ppa.14.22 Document Type: Review |
|
Times cited : (21)
|
|
References (0)
|